Fairfax Media network navigation

  • Home
  • Shares
  • Share details

AVITA MEDICAL LTD (AVH)


Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today » it's FREE! Already a member? Login now!


General Information
Company Name: Avita Medical Ltd
Stock Code: AVH
Website: www.avitamedical.com
GICS Sub-Industry: Biotechnology
Market Cap ($M): 47
Equiv. Shares (M): 325

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
 $ 0.145 $ 0.125 $ 0.150 $ 0.125 $ 0.120 3,142,717 $ 0.025  20.833 %

Company Overview

Business Description:
Avita Medical Ltd (AVH) is a medical technology company that develops and distributes regenerative and tissue-engineered products for the treatment of wounds, scars and skin defects. AVH also manufactures and sells spacers for the treatment of asthma. The company's products comprise regenerative medicine products (ReCell Autologous Spray-On-Skin) and respiratory products (Breath-A-Tech and Funhaler Paediatric Incentive Spacer).

Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2012  A -7.5 -3.2 -- 0.0 0.0 0.0 --
2011  A -4.0 -3.5 -- 0.0 0.0 0.0 --
2010  A -2.8 -2.6 -- 0.0 0.0 0.0 --
Source: Aspect actuals / Thomson IBES estimates

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2010 A 2011 F 2012 F 2010 A 2011 F 2012 F 2010 A 2011 F 2012 F
Avita Medical (AVH) $39 M -- -- -- -- -- -- 0.0000 -- --
CSL (CSL) $28,524 M 0.0878 0.2982 0.1222 30.7122 23.6580 21.0817 0.0143 0.0179 0.0203
Mesoblast (MSB) $1,886 M -- -- -- -- -- -- 0.0000 0.0000 0.0000
Starpharma (SPL) $227 M -- -- -- -- -- -- 0.0000 0.0000 0.0000
Sirtex Medical (SRX) $692 M 0.4803 0.3765 0.5516 41.0596 29.8292 19.2248 0.0081 0.0112 0.0170

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
AVH -- -- 4.04 -- 9.01
Market 0.94 12.5 0.82 1.96 2.44
Sector 1.28 15.2 2.36 0.58 7.16

Directors
Name Position Start Date
Dr William Dolphin Chief Executive Officer,Managing Director 05 March 2008
Mr Dalton Leslie Gooding Non-Executive Chairman 14 November 2002
Mr Ian Keith Macpherson Non-Executive Deputy Chairman 05 March 2008
Dr Paul Michael Watt Non-Executive Director 05 March 2008
Ms Fiona Melanie Wood Non-Executive Director 11 April 2006
Dr Michael S Perry Non-Executive Director 06 February 2013

Management
Name Position
Gabriel Chiappini Company Secretary
Lorraine Glover General Manager - Asia Pacific
Debra Leeves General Manager - Europe Middle East Africa
William Marshall VP Operations
Andrew Quick VP Research & Technology

Substantial Shareholders
Holding Name
46,461,441 (17.21%) National Nominees (Australian Ethical Equities Trust)

Calendar of Events
Date Event
26 February 2014 Report (Interim)
16 October 2013 Report (Annual)
30 August 2013 Report (Prelim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.

Advertisement

Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Optimising Your Portfolio

An educational booklet that will point out what you need to know to use options effectively for additional income and risk management.

More details...

News

Market recovery rides a big dipper

The Age 19/06/2013 | The bullish sentiments on the sharemarket earlier this year have been challenged by a correction that has taken the All Ordinaries Index down about 10 per cent from its May highs. Many investors are now asking how deep the current correction is likely to be.

Be prudent and don't take the market at face value

The Age 19/06/2013 | Done well, value investing is a successful, safe way to invest. The logic of the approach - buying an asset for less than its underlying value - is irrefutable.

Go for broke - insolvency can be the best solution

The Age 19/06/2013 | Snowballing debts and no means to repay them ... going bankrupt is the last-ditch option for those in a financial hole too deep to climb out from.

Often overlooked, micro caps are offering value

The Age 19/06/2013 | One of the weapons an individual has over institutions is time, and with real value emerging at the micro-cap end of the market, smaller stocks are an area worth holding on to.

Sun rises once more on Japan

The Age 19/06/2013 | Spending 10 days in Japan gives one a good overview of what they call "Abenomics" and its impact, and that includes also being here for one of the biggest drops on the Japanese market in weeks.

No rally after Lend Lease reassurance

The Age 19/06/2013 | Lend Lease has moved to allay investors' concerns with the issue of a formal profit guidance of between $540 million and $550 million for the full year, despite the weakness in the construction sector.

More...

Sponsored Links
Feedback Form